Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Youssef Afifi: The Thrombocytosis–Bleeding Paradox
Photo: vezeeta.com
Jun 18, 2026, 15:13

Youssef Afifi: The Thrombocytosis–Bleeding Paradox

Youssef Afifi, Consultant of Hematology and Internal Medicine at Cleopatra Hospitals Group, Consultant of Hematology and BMT at Police Academy, shared a post on LinkedIn:

“The thrombocytosis/bleeding paradox

More platelets mean more blood clots, right?

Actually, no. In hematology, we have a fascinating phenomenon where having ‘too many’ platelets dramatically increases the risk of bleeding.

This phenomenon perfectly illustrates why hematology is not always straight forward.

In myeloproliferative neoplasms like Essential Thrombocythemia (ET), a moderate increase in platelets predictably raises the risk of thrombosis. But once that platelet count crosses an extreme threshold – typically more than 1,000,000 or 1,500,000/μL—the script flips.

The patient’s bleeding risk skyrockets.

Why does this happen?

It comes down to ‘Acquired von Willebrand Syndrome (aVWS)‘

Normally, von Willebrand Factor (vWF) acts like the biological glue that helps platelets stick to damaged blood vessels and to each other. The largest vWF molecules (high-molecular-weight multimers) are the stickiest and most effective.

When a patient has a massive overproduction of platelets, these millions of circulating platelets rapidly bind to and clear out those crucial vWF multimers.

Essentially, the sheer volume of platelets exhausts the body’s supply of its best clotting glue.

The result? A lot of functionally useless because they can’t stick together.

This is why managing extreme thrombocytosis requires nuance.

Automatically giving aspirin to a patient with a platelet count of 1.5 million to “prevent clots” can actually trigger severe gastrointestinal or mucosal bleeding.

Instead, the focus often shifts to cytoreductive therapy to bring the absolute count down, which allows the vWF levels to recover and normalizes hemostasis.”

Youssef Afifi: The Thrombocytosis–Bleeding Paradox

Stay updated with Hemostasis Today.

Acquired von Willebrand Syndrome AVWS bleeding Essential Thrombocythemia ET Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine Thrombocytosis VWF Willebrand Factor Youssef Afifi
NewsFeed